Back to Top

Knome blog


  

Omixon and Knome partner to offer advanced HLA typing for whole genome and exome level data

CAMBRIDGE, MA — June 3, 2013 – Knome Inc., the human genome interpretation company, today announced that its Services division will now provide its clients with advanced HLA typing capabilities as part of its whole genome and exome interpretation offerings. These capabilities will be powered by Omixon’s Targeted HLA Typing … more

  

Knome and Real Time Genomics Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS™100 System

Partnership to bring accurate and fast genome analysis to translational researchers CAMBRIDGE, MA –  May 6, 2013 – Knome Inc., the genome interpretation company, and Real Time Genomics, Inc., the genome analytics company, today announced that the Real Time Genomics (RTG) Variant platform will be integrated into every shipment of the knoSYS™100 interpretation … more

  

Thank you for visiting us at ASHG

For those who missed us, allow us to fill you in on the excitement… A contingent of Knomies went out to San Francisco from November 6-10 for the annual meeting of the American Society of Human Genetics. There we had the pleasure of engaging with a number of geneticists, genomicists, … more

Nature Biotechnology  

Direct-to-consumer genomics reinvents itself

An excerpt of an interesting article mentioning Knome [emphasis ours]: …Cambridge, Massachusetts–based Knome made one of the splashiest entries into the field, but has now turned entirely to contract research. The company began providing DTC whole-genome sequencing to independently wealthy individuals at a time when the price was still sky … more

  

Knome Introduces the knoSYS™100

First Plug-and-Play Human Genome Interpretation System – Big data technology breaks the genome interpretation bottleneck – An in silico genetic testing “lab in a box” – More than a dozen leading institutions join early access program   CAMBRIDGE, MA –  September 27, 2012 – Knome Inc. announced today that it … more